The notices it replaced
- Reissues: PAR-21-208 Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
- 2 steps back: PAR-18-437 Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)
- 3 steps back: PAR-15-079 Cutting-Edge Basic Research Awards (CEBRA) (R21)
- 4 steps back: PAR-12-086 Cutting-Edge Basic Research Awards (CEBRA) (R21)
- 5 steps back: PAR-09-222 Cutting-Edge Basic Research Awards (CEBRA) (R21)
- 6 steps back: PAR-06-209 Cutting-Edge Basic Research Awards (CEBRA) (R21)
- 7 steps back: PAR-03-017
Who won it before
114 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $24,806,857 in first-year total cost, median $207,334.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-G (09)]9
- Special Emphasis Panel[ZDA1 SXC-E (10)]9
- Special Emphasis Panel[ZDA1 SXM-M (22)]9
- Special Emphasis Panel[ZDA1 JXR-D (12)]7
- Special Emphasis Panel[ZDA1 SKP-D (03)]7
Most frequent institutions
- YALE UNIVERSITY7
- WASHINGTON UNIVERSITY5
- STATE UNIVERSITY NEW YORK STONY BROOK4
- UNIVERSITY OF CALIFORNIA, SAN DIEGO4
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Device-free, long-term monitoring of opioid circuit activity in individual mice exposed to fentanyl1R21DA062242-01A1 · under PAR-21-208 | CORDER, GREGORYSZABLOWSKI, JERZY OLGIERD | UNIVERSITY OF PENNSYLVANIA, PA | $454,251 | ZDA1 |
| 2025 | GPR6: A Circuit-Level Druggable Target in Cocaine Use Disorder1R21DA063306-01 · under PAR-21-208 | ALLEN, JOHN ACUNNINGHAM, KATHRYN A. | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $440,000 | ZDA1 |
| 2025 | Genetic analysis of psychoplasticity in C. elegans1R21DA060522-01A1 · under PAR-21-208 | LOCKERY, SHAWN R | UNIVERSITY OF OREGON, OR | $406,051 | ZDA1 |
| 2025 | Finding the missing parts of human genetics of substance use disorders1R21DA063120-01 · under PAR-21-208 | ZHOU, HANG | YALE UNIVERSITY, CT | $357,613 | ZDA1 |
| 2024 | Validating a novel chemogenetic strategy for opioid use disorder1R21DA057695-01A1 · under PAR-21-208 | SJULSON, LUCAS L | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $252,000 | ZDA1 |
| 2024 | Studying synaptic transmission under opioid exposure using hiPSC-derived midbrain model and hyperspectral fluorescence lifetime imaging1R21DA060543-01 · under PAR-21-208 | SEIDLITS, STEPHANIE KRISTINYEH, HSIN-CHIH | UNIVERSITY OF TEXAS AT AUSTIN, TX | $221,843 | ZDA1 |
| 2024 | Statistical methods for gene regulatory analysis of substance use disorder1R21DA060503-01 · under PAR-21-208 | DUREN, ZHANA | CLEMSON UNIVERSITY, SC | $190,625 | ZDA1 |
| 2024 | Engineering chemoproteomic tools for identifying molecular mechanisms of substance use disorders1R21DA059842-01 · under PAR-21-208 | KIM, CHRISTINA | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $189,579 | ZDA1 |
| 2024 | Microbial Biofilms as Regulators of Amphetamine Use Disorders1R21DA059844-01 · under PAR-21-208 | CARTER, ANGELA MICHELLEVELU, SADANANDAN E. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $185,625 | ZDA1 |
| 2023 | Surmounting substance use disorder using an ultra-long acting injectable platform.1R21DA057701-01 · under PAR-21-208 | JOSHI, NITINKARP, JEFFREY MICHAEL | BRIGHAM AND WOMEN'S HOSPITAL, MA | $255,860 | ZDA1 |
| 2023 | Longitudinal neural fingerprinting of opioid-use trajectories1R21DA058415-01A1 · under PAR-21-208 | YIP, SARAH | YALE UNIVERSITY, CT | $251,250 | ZDA1 |
| 2023 | Single-cell whole brain imaging of nicotine intoxication, dependence, and abstinence1R21DA057694-01 · under PAR-21-208 | GEORGE, OLIVIER | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $237,000 | ZDA1 |
| 2023 | High Content Functional Neuroanatomy of Endogenous GPCRs1R21DA057690-01 · under PAR-21-208 | O'NEILL, PATRICK ROSS | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $234,000 | ZDA1 |
| 2023 | A novel therapeutic application of closed-loop neuromodulation of the brain reward system in nicotine use disorder1R21DA057618-01 · under PAR-21-208 | BAKER, TRAVIS E.HEADLEY, DREW BATTENFIELD | RUTGERS THE STATE UNIV OF NJ NEWARK, NJ | $226,963 | ZDA1 |
| 2023 | The Rodent Electronic Nicotine Delivery System (RENDS): Behavior, physiology, and epigenetics1R21DA053818-01A1 · under PAR-21-208 | ODUM, AMY | UTAH STATE UNIVERSITY, UT | $215,103 | ZDA1 |
| 2023 | New Technology for In Vivo Monitoring the Brain Extracellular Proteome at High Spatial Resolution in Substance Abuse Models1R21DA057617-01 · under PAR-21-208 | KENNEDY, ROBERT T | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $201,758 | ZDA1 |
| 2023 | The Genetics of Impulsivity and Motivation1R21DA056241-01A1 · under PAR-21-208 | CHOW, CLEMENTROTHENFLUH, ADRIAN | UNIVERSITY OF UTAH, UT | $192,500 | ZDA1 |
| 2023 | Imaging neural, astrocytic and vascular synchronization to assess cocaine's effects on mPFC1R21DA057699-01 · under PAR-21-208 | DU, CONGWULING, HAIBINPAN, YINGTIAN | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $186,699 | ZDA1 |
| 2022 | Interrogation of dopaminergic activity using non-invasive ultrasound1R21DA055056-01A1 · under PAR-21-208 | DE LECEA, LUIS | STANFORD UNIVERSITY, CA | $237,964 | ZDA1 |
| 2022 | Development of Wireless Equipment for Autonomous Rodent Infusion Tasks1R21DA055047-01 · under PAR-18-437 | MASSALY, NICOLASMCCALL, JORDAN G. | WASHINGTON UNIVERSITY, MO | $210,977 | ZDA1 |
| 2022 | Decoding regulatory functions of genetic variants associated with substance use disorders1R21DA056177-01 · under PAR-21-208 | BENNER, CHRISTOPHER WTELESE, FRANCESCA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $197,500 | ZDA1 |
| 2021 | Ultra-fast high-resolution imaging of whole mouse brain for the study of drug addiction1R21DA052419-01 · under PAR-18-437 | FREYBERG, ZACHARYLOGAN, RYAN WWATSON, ALAN MICHAEL | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $249,919 | ZDA1 |
| 2021 | Resolving differences between clinical opioids at single neurons1R21DA051208-01A1 · under PAR-18-437 | MARGOLIS, ELYSSA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $242,250 | ZDA1 |
| 2021 | Reversal of Opioid-Induced Pathological Neuroplasticity Through Timed Electrical Stimulation1R21DA052568-01 · under PAR-18-437 | THOMAS, MARK JOHNWIDGE, ALIK S. | UNIVERSITY OF MINNESOTA, MN | $232,000 | ZDA1 |
| 2021 | Dual cavity baskets as nano antidotes for overdose with fentanyl and its derivatives1R21DA052444-01 · under PAR-18-437 | BADJIC, JOVICA | OHIO STATE UNIVERSITY, OH | $231,855 | ZDA1 |
| 2021 | Clear Volume Imaging with Machine Learning: a novel tool to identify brain-wide neuronal ensembles of opioid relapse in rat models1UG3DA053802-01 · under PAR-18-437 | CHEN, RONGGOLDEN, SAM | UNIVERSITY OF MARYLAND BALTIMORE, MD | $229,734 | ZDA1 |
| 2021 | Beta-caryophyllene (BCP) and cannabidiol (CBD) combination: HIV-1 chronic neuropathic pain1R21DA051226-01A1 · under PAR-18-437 | BENAMAR, KHALID | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $229,500 | ZDA1 |
| 2021 | Endocannabinoid system and HIV-related neuropathic pain1R21DA053824-01 · under PAR-18-437 | BENAMAR, KHALID | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $229,500 | ZDA1 |
| 2021 | The role of negative reinforcement in drug abuse1R21DA053820-01 · under PAR-18-437 | BANKS, MATTHEW L | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $219,063 | ZDA1 |
| 2021 | Novel cellular markers of drug-mediated calcium signaling in astrocytes1R21DA052447-01 · under PAR-18-437 | REISSNER, KATHRYN JOANNA | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $217,979 | ZDA1 |
| 2021 | Genetic analysis of effort discounting in C. elegans1R21DA053817-01 · under PAR-18-437 | LOCKERY, SHAWN R | UNIVERSITY OF OREGON, OR | $216,191 | ZDA1 |
| 2020 | Effects of a G protein signaling-biased mu opioid receptor agonist SR-17018 in primates1R21DA049580-01 · under PAR-18-437 | KO, MEI-CHUAN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $258,065 | ZDA1 |
| 2020 | An Innovative Wearable Sensor For The Early Detection and Prevention Of Fatal Opioid Overdose1R21DA049566-01A1 · under PAR-18-437 | IMPERATO-MCGINLEY, JULIANNE LKAN, EDWIN CKRIEGER, ANA C. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $241,916 | ZDA1 |
| 2020 | The Microbiome in opioid use and abuse1R21DA049565-01A1 · under PAR-18-437 | WHISTLER, CHERYL ALLYNEWHISTLER, JENNIFER L | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $241,710 | ZDA1 |
| 2020 | Cholinergic transmission abnormalities associated with smoking behavior in humans1R21DA051179-01 · under PAR-18-437 | MOELLER, SCOTT J | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $239,250 | ZDA1 |
| 2020 | Role of circHomer1 in synaptic plasticity and cocaine-seeking behavior1R21DA048651-01A1 · under PAR-18-437 | NEISEWANDER, JANET LPERRONE-BIZZOZERO, NORA IRMA | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $238,457 | ZDA1 |
| 2020 | Using combined EEG and non-invasive brain stimulation to examine and improve reward functioning in opioid use disorder1R21DA049574-01A1 · under PAR-18-437 | BAKER, TRAVIS E. | RUTGERS THE STATE UNIV OF NJ NEWARK, NJ | $234,000 | ZDA1 |
| 2020 | Genetically Encoded Fluorescent Biosensors for Single-Cell and Subcellular Opioid Pharmacokinetics1R21DA051194-01 · under PAR-18-437 | GU, LIANGCAI | UNIVERSITY OF WASHINGTON, WA | $233,250 | ZDA1 |
| 2019 | Purification of cell-type specific synaptic material using virally-expressed tags1R21DA048632-01A1 · under PAR-18-437 | SMITH, STEPHEN EDWARD PAUCHA | SEATTLE CHILDREN'S HOSPITAL, WA | $280,672 | ZDA1 |
| 2019 | Identifying Prefrontal Cortex Neural Ensembles in Cocaine-associated Memories1R21DA047121-01A1 · under PAR-18-437 | SORG, BARBARA A | LEGACY EMANUEL HOSPITAL AND HEALTH CENTER, OR | $262,893 | ZDA1 |
| 2019 | Application of Machine Vision to Determine the Influence of Sleep States and Social Interactions on Vulnerability to Drug Addiction1R21DA048634-01 · under PAR-18-437 | KUMAR, VIVEK | JACKSON LABORATORY, ME | $255,000 | ZDA1 |
| 2019 | Neuroimmune modulation of neuronal function during cocaine conditioning1R21DA049568-01 · under PAR-18-437 | KIRALY, DREWSHUMAN, TRISTAN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $254,250 | ZDA1 |
| 2019 | The DNA methylation code governing the ensemble representation of morphine-context association1R21DA048635-01 · under PAR-18-437 | PLEIL, KRISTEN ELIZABETHTOTH, MIKLOS | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $253,743 | ZDA1 |
| 2019 | Real-time fMRI neurofeedback of large-scale network dynamics in opioid use disorder1R21DA049583-01 · under PAR-18-437 | GARRISON, KATHLEEN A.SCHEINOST, DUSTINYIP, SARAH | YALE UNIVERSITY, CT | $251,250 | ZDA1 |
| 2019 | High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposure1R21DA049577-01 · under PAR-18-437 | LEE, HAKHOPENDYALA, GURUDUTT | MASSACHUSETTS GENERAL HOSPITAL, MA | $247,330 | ZDA1 |
| 2019 | Rapid and sensitive in vivo detection of opioid peptides1R21DA048650-01 · under PAR-18-437 | AL-HASANI, REAM | ST. LOUIS COLLEGE OF PHARMACY, MO | $243,248 | ZDA1 |
| 2019 | Dissecting Monoaminergic Physiology of Prefrontal Cortical Astrocytes1R21DA048497-01 · under PAR-18-437 | POSKANZER, KIRA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $240,563 | ZDA1 |
| 2019 | Drugs of abuse drive transmitter switching that causes drug-induced behavior1R21DA048633-01 · under PAR-18-437 | SPITZER, NICHOLAS CANADAY | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $236,250 | ZDA1 |
| 2019 | Isradipine and Virtual Reality Cue Exposure for Smoking Cessation1R21DA049539-01 · under PAR-18-437 | SMITS, JASPERYOUNG, CARA CALLOWAY | UNIVERSITY OF TEXAS AT AUSTIN, TX | $234,750 | ZDA1 |
| 2019 | Use of precision deuteration to determine the contribution of norbuprenorphine to buprenorphine-associated neonatal abstinence syndrome1R21DA049585-01 · under PAR-18-437 | BRENTS, LISA KAYE | UNIV OF ARKANSAS FOR MED SCIS, AR | $226,625 | ZDA1 |
| 2019 | Trans-synaptic optogenetics: reversible temporal control of activity at defined synaptic connections1R21DA049569-01 · under PAR-18-437 | COPITS, BRYANO'NEILL, PATRICK ROSS | WASHINGTON UNIVERSITY, MO | $212,007 | ZDA1 |
| 2019 | Whole-brain mapping of opiate-sensitive circuits in Drosophila1R21DA048622-01 · under PAR-18-437 | KAUN, KARLA R. | BROWN UNIVERSITY, RI | $203,125 | ZDA1 |
| 2019 | Supramolecular Nanovaccines for Opioid Use Disorders1R21DA047138-01 · under PAR-15-079 | RALEIGH, MICHAEL DENNISRUDRA, JAI | WASHINGTON UNIVERSITY, MO | $193,057 | ZDA1 |
| 2019 | ATAC-ing dopaminergic cell identity with single-cell resolution1R21DA049635-01 · under PAR-18-437 | ROTHENFLUH, ADRIAN | UNIVERSITY OF UTAH, UT | $190,625 | ZDA1 |
| 2018 | Application of intein-based chemical methods to directly manipulate neuronal histone modifications in rodent models of addiction1R21DA044767-01A1 · under PAR-15-079 | DAVID-SHTERNBERG, YAEL EMAZE, IAN S. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $230,626 | ZDA1 |
| 2018 | Measure Mu-opioid Receptor Desensitization in vivo1R21DA047133-01 · under PAR-15-079 | WEY, HSIAO-YING | MASSACHUSETTS GENERAL HOSPITAL, MA | $205,079 | ZDA1 |
| 2018 | Light activated CRISPR epigenome editing in cocaine abuse1R21DA046227-01 · under PAR-15-079 | LOBO, MARY KAY | UNIVERSITY OF MARYLAND BALTIMORE, MD | $202,369 | ZDA1 |
| 2018 | Deep learning-based image analysis for assessing real-time smoking risk1R21DA047131-01 · under PAR-15-079 | MCCLERNON, FRANCIS JOSEPH | DUKE UNIVERSITY, NC | $200,208 | ZDA1 |
| 2018 | Bile acid signaling as a pharmacological target for the treatment of cocaine abuse1R21DA043960-01A1 · under PAR-15-079 | FLYNN, CHARLES RGALLI, AURELIO | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $195,885 | ZDA1 |
| 2018 | Trans-Synaptic Luminescent Opsins:Developing pathway-, cell type-, and synapse-specific optogenetics1R21DA047108-01 · under PAR-15-079 | HUANG, YANHUA H | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $195,625 | ZDA1 |
| 2018 | FGF21 and Drug Abuse1R21DA044766-01A1 · under PAR-15-079 | BIDLACK, JEAN M | UNIVERSITY OF ROCHESTER, NY | $192,500 | ZDA1 |
| 2018 | Imaging the monoaminergic midbrain and cognitive control in cocaine addiction1R21DA044749-01A1 · under PAR-15-079 | LI, CHIANG-SHAN RAY | YALE UNIVERSITY, CT | $183,750 | ZDA1 |
| 2018 | Imaging the behaviorally evoked neural ensemble dynamics of the locus coeruleus in healthy and addicted brains1R21DA046183-01 · under PAR-15-079 | SCHNITZER, MARK J | STANFORD UNIVERSITY, CA | $176,488 | ZDA1 |
| 2018 | Allosteric regulation and phosphorylation homeostasis of PEA-15 in protection of brain microvascular endothelial cells against methamphetamine and HIV-1 Tat1R21DA046223-01 · under PAR-15-079 | WEI, YUFENG | NEW JERSEY CITY UNIVERSITY, NJ | $143,355 | ZDA1 |
| 2017 | Effects of a G protein-biased mu opioid receptor agonist PZM21 in primates1R21DA044775-01 · under PAR-15-079 | KO, MEI-CHUAN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $219,436 | ZDA1 |
| 2017 | Syringe Injectable Electronics Platform for Chronic Mapping and Modulation of Neural Circuits in Addiction1R21DA043985-01 · under PAR-15-079 | LIEBER, CHARLES M | HARVARD UNIVERSITY, MA | $211,250 | ZDA1 |
| 2017 | Imaging Synaptic Density in the Cocaine-Addicted Brain In Vivo using 11C UCB J PET1R21DA044005-01 · under PAR-15-079 | MALISON, ROBERT T | YALE UNIVERSITY, CT | $209,375 | ZDA1 |
| 2017 | Neurobiology of care giving in opioid dependent mothers1R21DA043983-01A1 · under PAR-15-079 | LANGLEBEN, DANIEL D | UNIVERSITY OF PENNSYLVANIA, PA | $206,528 | ZDA1 |
| 2017 | Addiction, Gender and Endocrine Disruptors1R21DA042599-01A1 · under PAR-15-079 | LYNCH, WENDY JEANRISSMAN, EMILIE F. | NORTH CAROLINA STATE UNIVERSITY RALEIGH, NC | $203,397 | ZDA1 |
| 2017 | Neural circuit impacts of hallucinogens1R21DA041857-01A1 · under PAR-15-079 | JI, DAOYUN | BAYLOR COLLEGE OF MEDICINE, TX | $198,125 | ZDA1 |
| 2017 | Explore in vivo functional connectivity at cellular resolution in drugged brains1R21DA044007-01A1 · under PAR-15-079 | GUO, SU | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $198,125 | ZDA1 |
| 2017 | Does GPR119 mediate the beneficial metabolic effects of THC?1R21DA044004-01 · under PAR-15-079 | MACKIE, KENNETH | TRUSTEES OF INDIANA UNIVERSITY, IN | $196,406 | ZDA1 |
| 2017 | Microglia and Opioid Withdrawal1R21DA044757-01 · under PAR-15-079 | NEUMAIER, JOHN F | UNIVERSITY OF WASHINGTON, WA | $193,750 | ZDA1 |
| 2017 | Nanoprobes for neurotransmitter-sensitive molecular fMRI in addiction research1R21DA044748-01 · under PAR-15-079 | JASANOFF, ALAN | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $193,375 | ZDA1 |
| 2017 | Robotics may help unravel the biological determinants of substance use disorders: studies in zebrafish1R21DA042558-01A1 · under PAR-15-079 | PORFIRI, MAURIZIO | NEW YORK UNIVERSITY, NY | $173,125 | ZDA1 |
| 2017 | Optical montoring of modulatory neurotransmitter levels using new infrared nanonsensors1R21DA044010-01A1 · under PAR-15-079 | WILBRECHT, LINDA E | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $138,395 | ZDA1 |
| 2017 | Nanoparticle-Mesenchymal Stem Cell conjugates for cell therapy in drug addiction1R21DA043959-01 · under PAR-15-079 | POPOVTZER, RACHELAYADID, GAL MOSHE | BAR-ILAN UNIVERSITY | $102,340 | ZDA1 |
| 2016 | Enzympharmacotherapy for attenuating nicotine's psychoactive effects1R21DA041839-01A1 · under PAR-15-079 | JANDA, KIM | SCRIPPS RESEARCH INSTITUTE, THE, CA | $240,625 | ZDA1 |
| 2016 | Causally connecting neural activity to behavior with caged compounds1R21DA041725-01 · under PAR-15-079 | NICOLA, SALEEM M | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC, NY | $208,750 | ZDA1 |
| 2016 | The Unlearning of Stimulus-Outcome Associations through Intracortical Microstimulation1R21DA041791-01 · under PAR-15-079 | WALLIS, JONI D | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $195,465 | ZDA1 |
| 2016 | A Novel Mechanism for Decreasing Opioid Reward1R21DA042584-01 · under PAR-15-079 | HOHMANN, ANDREA GRACEREBEC, GEORGE VINCENT | TRUSTEES OF INDIANA UNIVERSITY, IN | $195,156 | ZDA1 |
| 2016 | Optical platform to image neuronal and vascular effects of cocaine in awake rodents1R21DA042597-01 · under PAR-15-079 | DU, CONGWUPAN, YINGTIAN | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $195,071 | ZDA1 |
| 2016 | Lipidomics analysis of identified single neurons in the adult rodent brain1R21DA041776-01 · under PAR-15-079 | PIOMELLI, DANIELE | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $193,125 | ZDA1 |
| 2016 | Quantitative Neurovascular Imaging for Drug Abuse Research1R21DA042583-01 · under PAR-15-079 | SRIDHAR, SRINIVAS | NORTHEASTERN UNIVERSITY, MA | $193,125 | ZDA1 |
| 2016 | In vivo imaging of dynamic structural plasticity driving morphine conditioned place preference1R21DA042581-01 · under PAR-15-079 | HAN, EDWARD BINGMORON-CONCEPCION, JOSE A | WASHINGTON UNIVERSITY, MO | $190,625 | ZDA1 |
| 2016 | Technology for Identification of Epiproteomes in Tissue Samples1R21DA041822-01 · under PAR-15-079 | TACKETT, ALAN | UNIV OF ARKANSAS FOR MED SCIS, AR | $186,250 | ZDA1 |
| 2016 | Cell-type Specific Psychostimulant Effects on the Neuronal Translatome1R21DA040454-01A1 · under PAR-15-079 | NAIRN, ANGUS C. | YALE UNIVERSITY, CT | $183,750 | ZDA1 |
| 2015 | Cocaine abuse and plasticity in the lateral hypothalamus1R21DA040458-01 · under PAR-12-086 | SANNA, PIETRO P | SCRIPPS RESEARCH INSTITUTE, THE, CA | $247,175 | ZDA1 |
| 2015 | A transgenic model of opioid tolerance and drug discovery1R21DA040406-01 · under PAR-12-086 | GRILL, BROCKMARTEMYANOV, KIRILL A. | SCRIPPS FLORIDA, FL | $240,000 | ZDA1 |
| 2015 | Dynamic Contrast-Enhanced MRI to Measure Blood-Brain Barrier Permeability in Substance Abusers1R21DA040436-01 · under PAR-12-086 | COMER, SANDRA D | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $213,761 | ZDA1 |
| 2015 | Impact of Cannabinoid Use on HIV-related Brain Alterations in Young Adults1R21DA037667-01A1 · under PAR-12-086 | FENNEMA-NOTESTINE, CHRISTINENICHOLS, SHARON L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $193,750 | ZDA1 |
| 2015 | Optogenetic Toolbox for Studying Regulators of G-Protein Signaling in Addiction1R21DA040434-01 · under PAR-12-086 | CHOW, BRIAN Y | UNIVERSITY OF PENNSYLVANIA, PA | $193,340 | ZDA1 |
| 2015 | A novel RNA-guided platform for dissecting cannabinoid signaling in reward circuit development1R21DA038447-01A1 · under PAR-12-086 | GUO, SU | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $192,424 | ZDA1 |
| 2015 | High throughput multicompartment culture chambers to develop neurocircuit models of addiction risk1R21DA039686-01 · under PAR-12-086 | HART, RONALD PPANG, ZHIPING P.ZAHN, JEFFREY D | RUTGERS, THE STATE UNIV OF N.J., NJ | $191,622 | ZDA1 |
| 2015 | A novel approach for identifying addiction vulnerability in animals.1R21DA037728-01A1 · under PAR-12-086 | GEWIRTZ, JONATHANHARRIS, ANDREW CHARLES | UNIVERSITY OF MINNESOTA, MN | $191,495 | ZDA1 |
| 2015 | Flexible and inducible gene knockdown in rat neurons: BDNF and drug addiction1R21DA039681-01 · under PAR-12-086 | WONG-RILEY, MARGARET TT | MEDICAL COLLEGE OF WISCONSIN, WI | $191,250 | ZDA1 |
| 2015 | Beta-ketoamphetamines: Window to the Neurotoxic Mechanisms of Methamphetamine1R21DA039667-01 · under PAR-12-086 | KUHN, DONALD M | WAYNE STATE UNIVERSITY, MI | $190,938 | ZDA1 |
| 2015 | Preserving opioid analgesia using a novel adenosinergic approach1R21DA040305-01 · under PAR-12-086 | SALVEMINI, DANIELA | SAINT LOUIS UNIVERSITY, MO | $189,375 | ZDA1 |
| 2015 | Development of a rat model of cannabis smoke self-administration1R21DA039701-01 · under PAR-12-086 | MAURER, ANDREW PORTERSETLOW, BARRY | UNIVERSITY OF FLORIDA, FL | $187,500 | ZDA1 |
| 2015 | Exploring nucleocytoplasmic IEG mRNA export in striatal neuron subpopulations1R21DA037736-01A1 · under PAR-12-086 | KEEFE, KRISTEN A | UNIVERSITY OF UTAH, UT | $186,250 | ZDA1 |
| 2015 | Theranostic Pain Nanomedicines: imaging inflammation, reducing pain and need for opioids1R21DA039621-01 · under PAR-12-086 | JANJIC, JELENA M | DUQUESNE UNIVERSITY, PA | $165,000 | ZDA1 |
| 2014 | Neurodevelopmental impact of prenatal exposure to prescription pain medication1R21DA036376-01A1 · under PAR-12-086 | MILLER, COURTNEY A | SCRIPPS FLORIDA, FL | $236,250 | ZDA1 |
| 2014 | GLP-1 Receptors and Psychostimulant Addiction1R21DA035588-01A1 · under PAR-12-086 | GALLI, AURELIOSTANWOOD, GREGG D | VANDERBILT UNIVERSITY, TN | $235,125 | ZDA1 |
| 2014 | Menthol as a chaperone for nicotonic receptors1R21DA037743-01 · under PAR-12-086 | LESTER, HENRY A. | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $208,125 | ZDA1 |
| 2014 | Probing the circadian clock in zebrafish larvae with in situ single cell transcri1R21DA038468-01 · under PAR-12-086 | CAI, LONG | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $208,125 | ZDA1 |
| 2014 | Using Control Systems to Predict Individualized Dynamics of Nicotine Cravings1R21DA038467-01 · under PAR-12-086 | MUJICA-PARODI, LILIANNE R | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $206,543 | ZDA1 |
| 2014 | Optogenetic Targeting of mGluR5 Receptor Signaling1R21DA037741-01 · under PAR-12-086 | OLIVE, M. FOSTER | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $192,865 | ZDA1 |
| 2014 | Long noncoding RNAs and chromatin regulation in cocaine addiction1R21DA035592-01A1 · under PAR-12-086 | WAHLESTEDT, CLAES ROBERT | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $191,875 | ZDA1 |
| 2014 | Heroin Addiction: Predicting Vulnerability & Identification of a Novel Treatment1R21DA035608-01A1 · under PAR-12-086 | LEVENSON, ROBERT | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $191,250 | ZDA1 |
| 2014 | DEVELOPMENT OF A NOVEL APPROACH TO STUDY ALTERNATIVE TRANSLATION IN THE CNS1R21DA038458-01 · under PAR-12-086 | DOUGHERTY, JOSEPH D | WASHINGTON UNIVERSITY, MO | $190,625 | ZDA1 |
| 2014 | Drug repurposing study for tobacco dependence treatment using zebrafish1R21DA035546-01A1 · under PAR-12-086 | KLEE, ERIC W | MAYO CLINIC ROCHESTER, MN | $184,152 | ZDA1 |
| 2014 | A role for vitamin D in drug addiction1R21DA037657-01 · under PAR-12-086 | DILEONE, RALPH J | YALE UNIVERSITY, CT | $177,375 | ZDA1 |
| 2014 | Theory of Resurgence of Cocaine Seeking1R21DA037725-01 · under PAR-12-086 | SHAHAN, TIMOTHY A | UTAH STATE UNIVERSITY, UT | $173,550 | ZDA1 |
| 2014 | Opposing Roles of Distinct Output Projections From Prefrontal Cortex1R21DA037744-01 · under PAR-12-086 | SMITH, RACHEL J | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $170,475 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.